Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Open House Drug Discount Agreements Nintedanib, Atc L01ex09 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Beclometasone (excl. Dafo Ihp), Atc R03ba01 For The Period 01.05.26-30.04.28 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredients Sofosbuvir And Velpatasvir For The Period 01.05.26-30.04.28. Sofosbuvir, Velpatasvir 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Nintedanib For The Period 01.05.26-30.04.28 (plus Option For 1x12 Months). Nintedanib, Vargatef, Generika 2026-09-12
United States 21-0072 - Emergency Shelter Care (esc) - Closing: 9/30/2028 12:00 Pm 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Glycerol Trinitrate, Atc C05ae01 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-12
Austria Market Exploration Molecular Diagnostic Analysis System 2026-09-12
Germany Open House Pharmaceutical Discount Contracts Clobetasol, Atc D07ad01 2026-09-12
Germany Open House Drug Discount Contracts Clindamycin And Benzoyl Peroxide, Atc D10af54 2026-09-12
Germany Open House Drug Discount Contracts For The Active Ingredient Pancreatin, Lipase-containing Multi-enzymes, Atc A09aa02 2026-09-12
Whats app